McKesson Corporation $MCK Shares Sold by Wealthfront Advisers LLC

Wealthfront Advisers LLC decreased its holdings in McKesson Corporation (NYSE:MCK) by 6.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 25,557 shares of the company’s stock after selling 1,729 shares during the quarter. Wealthfront Advisers LLC’s holdings in McKesson were worth $19,744,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of MCK. Vanguard Group Inc. boosted its position in shares of McKesson by 2.0% in the second quarter. Vanguard Group Inc. now owns 12,072,090 shares of the company’s stock worth $8,846,186,000 after acquiring an additional 232,286 shares during the last quarter. Geode Capital Management LLC raised its stake in McKesson by 4.1% during the second quarter. Geode Capital Management LLC now owns 2,820,724 shares of the company’s stock worth $2,057,065,000 after purchasing an additional 112,224 shares during the period. Alliancebernstein L.P. boosted its holdings in shares of McKesson by 150.4% in the 2nd quarter. Alliancebernstein L.P. now owns 2,268,015 shares of the company’s stock valued at $1,661,956,000 after purchasing an additional 1,362,386 shares during the last quarter. Norges Bank purchased a new stake in shares of McKesson during the 2nd quarter valued at $1,346,661,000. Finally, Arrowstreet Capital Limited Partnership increased its holdings in shares of McKesson by 56.4% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 1,236,536 shares of the company’s stock worth $906,109,000 after buying an additional 446,060 shares during the last quarter. Institutional investors and hedge funds own 85.07% of the company’s stock.

Insider Transactions at McKesson

In related news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the business’s stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $955.00, for a total value of $313,240.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP Thomas L. Rodgers sold 276 shares of the stock in a transaction dated Monday, January 5th. The shares were sold at an average price of $816.18, for a total value of $225,265.68. Following the completion of the transaction, the executive vice president directly owned 2,268 shares of the company’s stock, valued at $1,851,096.24. This represents a 10.85% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.08% of the stock is currently owned by insiders.

McKesson Stock Down 2.9%

Shares of NYSE:MCK opened at $934.41 on Wednesday. The company has a market capitalization of $114.46 billion, a price-to-earnings ratio of 26.87, a price-to-earnings-growth ratio of 1.55 and a beta of 0.40. The company has a 50 day moving average of $832.63 and a two-hundred day moving average of $783.87. McKesson Corporation has a 52-week low of $585.22 and a 52-week high of $971.93.

McKesson (NYSE:MCK) last posted its earnings results on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. The business had revenue of $106.16 billion for the quarter, compared to analysts’ expectations of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The business’s revenue for the quarter was up 11.4% compared to the same quarter last year. During the same period in the previous year, the company posted $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, equities analysts anticipate that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be paid a dividend of $0.82 per share. The ex-dividend date is Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson’s dividend payout ratio (DPR) is currently 9.43%.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the company. Weiss Ratings cut McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a report on Thursday, February 5th. Robert W. Baird set a $968.00 price objective on McKesson in a research note on Wednesday, January 14th. Evercore reissued an “outperform” rating and set a $1,000.00 target price on shares of McKesson in a research report on Thursday, November 6th. TD Cowen lifted their price target on shares of McKesson from $1,000.00 to $1,012.00 and gave the company a “buy” rating in a research report on Thursday, February 5th. Finally, Zacks Research lowered shares of McKesson from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 25th. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $937.07.

More McKesson News

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: JPMorgan upgraded MCK to “Overweight” and raised its price target from $983 to $1,107, implying notable upside vs. recent levels — this is a clear bullish catalyst for investor demand. Benzinga
• Positive Sentiment: High-profile media/TV support (Jim Cramer praising McKesson) can boost retail interest and short-term buying flows. Cramer piece
• Positive Sentiment: Recent earnings beat and FY26 EPS guidance (38.80–39.20) plus a new quarterly dividend ($0.82/share) support the fundamental bull case for long-term investors. MarketBeat summary
• Neutral Sentiment: McKesson is attracting investor attention on screens (Zacks notes it’s among most-watched stocks), which can increase volatility but doesn’t itself imply direction. Zacks
• Neutral Sentiment: Coverage on automation and robotics (could improve logistics/efficiency long term) highlights an operational upside but is speculative for near-term earnings. Pharma-Technology
• Negative Sentiment: Insider selling: CAO Napoleon Rutledge Jr. sold 328 shares (filed with SEC) — small in size relative to the company but often interpreted negatively by some investors. InsiderTrades
• Negative Sentiment: McKesson reported flat revenues in its Medical‑Surgical segment, which may concern investors focused on near-term organic growth and margin leverage. HME News

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.